AXSM
Axsome Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.42 / 10
Underperform
Corporate fundamentals are rated weak (2.4/10). Key concerns include high Days sales outstanding (103.27) and negative Revenue-MV, while moderate strengths are seen in Interest coverage ratio (15.48) and Total operating revenue growth (65.77% YoY). Overall, the fundamental picture is constrained.
Analysis Checks(6/10)
Revenue-MV
Value-1.32
Score1/3
Weight12.21%
1M Return4.24%
Value-1.32
Score1/3
Weight12.21%
1M Return4.24%
Days sales outstanding
Value103.27
Score0/3
Weight-10.75%
1M Return-5.18%
Value103.27
Score0/3
Weight-10.75%
1M Return-5.18%
Net income-Revenue
Value-0.17
Score2/3
Weight24.28%
1M Return8.45%
Value-0.17
Score2/3
Weight24.28%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.43%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.43%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value65.77
Score2/3
Weight2.60%
1M Return1.11%
Value65.77
Score2/3
Weight2.60%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight24.25%
1M Return8.45%
Value0.46
Score2/3
Weight24.25%
1M Return8.45%
PB-ROE
Value7.79
Score0/3
Weight7.24%
1M Return2.72%
Value7.79
Score0/3
Weight7.24%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value65.77
Score2/3
Weight1.00%
1M Return0.43%
Value65.77
Score2/3
Weight1.00%
1M Return0.43%
Cash-MV
Value-4.94
Score2/3
Weight23.85%
1M Return8.41%
Value-4.94
Score2/3
Weight23.85%
1M Return8.41%
Revenue-MV
Value-1.32
Score1/3
Weight12.21%
1M Return4.24%
Value-1.32
Score1/3
Weight12.21%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value65.77
Score2/3
Weight2.60%
1M Return1.11%
Value65.77
Score2/3
Weight2.60%
1M Return1.11%
Days sales outstanding
Value103.27
Score0/3
Weight-10.75%
1M Return-5.18%
Value103.27
Score0/3
Weight-10.75%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight24.25%
1M Return8.45%
Value0.46
Score2/3
Weight24.25%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight24.28%
1M Return8.45%
Value-0.17
Score2/3
Weight24.28%
1M Return8.45%
PB-ROE
Value7.79
Score0/3
Weight7.24%
1M Return2.72%
Value7.79
Score0/3
Weight7.24%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.43%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.43%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value65.77
Score2/3
Weight1.00%
1M Return0.43%
Value65.77
Score2/3
Weight1.00%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Cash-MV
Value-4.94
Score2/3
Weight23.85%
1M Return8.41%
Value-4.94
Score2/3
Weight23.85%
1M Return8.41%
Is AXSM undervalued or overvalued?
- AXSM scores 2.42/10 on fundamentals and holds a Premium valuation at present. Backed by its -236.52% ROE, -40.89% net margin, -37.27 P/E ratio, 124.82 P/B ratio, and 29.03% earnings growth, these metrics solidify its Underperform investment rating.
